Khiron Life Sciences Corp. (KHRNF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 22, 2025
0.00%
Market Cap 232.00
Revenue (ttm) 11.75M
Net Income (ttm) -22.33M
Shares Out 232.41M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 58,520
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0020
Beta 18.48
RSI 43.94
Earnings Date n/a

About Khiron Life Sciences

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic ... [Read more]

Sector Healthcare
Founded 2012
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol KHRNF
Full Company Profile

Financial Performance

In 2021, Khiron Life Sciences's revenue was 12.80 million, an increase of 59.60% compared to the previous year's 8.02 million. Losses were -33.13 million, 37.8% more than in 2020.

Financial numbers in CAD Financial Statements

News

Khiron Life Sciences Announces Closing of the Sale of Its European Business

Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) ("Khiron" or the "Company") is pleased to announce that the Company has completed the sa...

1 year ago - Newsfile Corp

Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business

Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) ("Khiron" or the "Company") today announced that the Company and 2518542 Alberta Ltd....

1 year ago - Newsfile Corp

Khiron Life Sciences Agrees to $500,000 Secured Deposit

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) -  Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) ("Khiron" or the "Company") announced today that the Company has agreed to a $500,000 non-in...

2 years ago - Newsfile Corp

Medical First: Germany Strengthens Reimbursement of Medical Cannabis

On 16 March 2023, after five years of observational data collection the German Federal Joint Committee (G-BA) decided on the future regulations that will govern the prescription of medical cannabis as...

2 years ago - Newsfile Corp

Khiron Completes First Phase of Business Optimization

First phase of optimization was focused on streamlining Colombian operations, resulting in a moving forward annualized cost reduction of CAD 5.0 million, representing overall cost savings of more than...

2 years ago - Newsfile Corp

Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option

Toronto, Ontario--(Newsfile Corp. - April 4, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) ("Khiron" or the "Company") is pleased to announce that it has closed today its previously a...

2 years ago - Newsfile Corp

Khiron Closes Additional Loan with Investment-Grade Bank

The term loan, provided by one of Colombia's largest and traditional private banks, provides immediate access to liquidity, and further strengthens Khiron's credibility with long-established banking i...

2 years ago - Newsfile Corp

Khiron Closes Revolving Credit Facility with Financing Company in Colombia

Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), announces that its wholly owned subsidiary Ze...

2 years ago - Newsfile Corp

Khiron begins dispensation of insurance-covered prescriptions in Colombia

Following the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate. TORONTO , Jan. 19, 2...

2 years ago - PRNewsWire

NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient

Zerenia™ Clinics UK, wholly owned by Khiron, succeeds at having the NHS reimbursing both the cost of cannabis-based treatment and clinic fees to its first patient Khiron trains doctors and nurses at a...

2 years ago - PRNewsWire

Khiron wins first medical cannabis contract with Colombia's largest public insurance company

On December 27, 2022, Zerenia (Khiron´s wholly owned medical cannabis clinic network) signed a contract with CAPITAL SALUD EPS, Colombia´s largest public insurance company, under which Zerenia will pr...

2 years ago - PRNewsWire

Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products

On December 30, 2022, the Ministry of Health of Colombia reaffirmed the inclusion of plant-based medical cannabis products, i.e., Khiron products, in the mandatory insurance coverage system Starting J...

2 years ago - PRNewsWire

Khiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call Transcript

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q3 2022 Earnings Conference Call November 30, 2022 11:00 AM ET Company Participants Alvaro Torres - CEO and Co-Founder Helen Bellewood - Interim CFO Franziska ...

2 years ago - Seeking Alpha

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing product portfolio, and the specialized cannabis cli...

2 years ago - PRNewsWire

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

TORONTO , Nov. 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin Am...

2 years ago - PRNewsWire

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom

Through its newly acquired EU-GMP distribution hub in Germany, Khiron expands its product portfolio and geographic reach within Europe to Germany, UK, and Switzerland. Switzerland: Khiron enters the S...

2 years ago - PRNewsWire

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California

New products to be distributed through Khiron's new wholly-owned subsidiary Pharmadrug Production GmbH Khiron introduces new THC-dominant full-spectrum extract KHIRIOX 25/1, and non-irradiated flower ...

3 years ago - PRNewsWire

Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Call Transcript

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q2 2022 Earnings Conference Call August 29, 2022 10:00 AM ET Company Participants Paola Ricardo - Investor Relations Alvaro Torres - CEO and Co-Founder Helen B...

3 years ago - Seeking Alpha

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target markets Recorded its lowest ever Adjusted EBITDA loss in Q2 ...

3 years ago - PRNewsWire

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

TORONTO , Aug. 22, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin Amer...

3 years ago - PRNewsWire

Khiron Life Sciences Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), a global leader in medical cannabis throughout ...

3 years ago - Newsfile Corp

Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic

Continued Global Growth of Khiron's Proven ZereniaTM Clinic ModelFocused on Patients, Physician Education and Innovation New clinic is in the district of Ipanema in Rio de Janeiro, a city with more th...

3 years ago - PRNewsWire

Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities

Acquisition provides Khiron with an EU-GMP European manufacturing and distribution hub for medical cannabis and other pharmaceutical products The acquisition of Pharmadrug Production GmbH provides Khi...

3 years ago - PRNewsWire

Khiron Appoints Helen Bellwood (ACA) as Interim CFO

TORONTO , July 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin Amer...

3 years ago - PRNewsWire

Medical Cannabis Leader Khiron Continues Global Expansion into Spain

Khiron's Medical Clinics and Distribution Growth Throughout Europe Follows Succes s in Latin American Marketplace Since establishing a Spanish subsidiary in 2019, Khiron's scientific and medical team ...

3 years ago - PRNewsWire